AT-7519 is a small-molecule inhibitor of cyclin-dependent kinases (CDK). AT-7519 caused cell cycle arrest followed by apoptosis in human tumor cells and inhibited tumor growth in human tumor xenograft models. AT-7519 is being studied for its potential therapeutic benefits in cancer patients. Molecular Formula: C16H17Cl2N5O2 Molecular Weight: 382.24 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
382.24
CAS Number:
[844442-38-2]
* VAT and and shipping costs not included. Errors and price changes excepted